Navigo Invest Q4 2024: Strong quarter for Chemgroup, soft figures for other subsidiaries - Redeye

Redeye provides its initial take on Navigo’s Q4 2024 report, which beat our sales estimate but missed our earnings projection. We judge that the report's positives include strong top-line growth and profitability for Chemgroup. Notable negatives include adjusted EBIT misses for other subsidiaries even after accounting for goodwill impairments during the quarter.

Länk till analysen i sin helhet: https://www.redeye.se/research/1081734/navigo-invest-q4-2024-strong-quarter-for-chemgroup-soft-figures-for-other-subsidiaries?utm_source=finwire&utm_medium=RSS